Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years

Hely, Mariese A., Morris, John G.L., Reid, Wayne G.J., Trafficante, Robert·2005·Movement Disorders
DOI 10.1002/mds.20324

Cited by (1,000)

Items 801–900 of 1,000

  1. Impact of Preoperative Cognition on Motor Improvement in Bilateral Subthalamic Nucleus-Deep Brain Stimulation for Parkinson's Disease
    Vibuthi Sisodia, Rosalie Ursinus, Gert J. Geurtsen, Yarit Wiggerts, Peter Richard Schuurman, Martijn Beudel, Rob M. A. de Bie, Bart E.K.S. Swinnen · 2024 · Neuromodulation Technology at the Neural Interface
  2. Contextes de négociation, processus de recomposition
    Mathilde Lancelot · 2022 · Alter
  3. In PD, Non-Invasive Trans-Spinal Magnetic Stimulation Enhances the Effect of Transcranial Magnetic Stimulation on Axial Motor Symptoms: A Double-Blind Randomized Clinical Trial
    Eman Mohamed Khedr, Nourelhoda A. Haridy, Mohammad A. Korayem, Ahmed Mamdouh Tawfik, Ahmed A. Hamed · 2024 · Neurorehabilitation and neural repair
  4. Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease
    Neal M. Farber, Santiago Perez‐Lloret, Elkan R. Gamzu · 2015 · Current Topics in Medicinal Chemistry
  5. The development of visual neuroimaging research of acupuncture in the treatment of Parkinson’s disease
    Yuan Yang, Suhua Miao, Rongsong Zhou, Yu Ma, Yuqi Zhang · 2019 · Brain Science Advances
  6. Recurrent falls in people with Parkinson's disease
    Lorena Rosa S. Almeida, Serene Sulyn Paul, Guilherme T. Valença · 2020 · Elsevier eBooks
  7. Parkinson’s Disease: Diagnosis, Motor Symptoms and Non-motor Features
    Joseph J. Jankovic · 2013
  8. Sleep Quality and Cognitive Impairment in Patients with Parkinson’s Disease in Iran
    Narges Sahebzadeh, Morteza Mazloum Farsi Baf, Seyed Mehran Homam · 2016 · Turkish Journal Of Neurology
  9. PET - diagnostics of cognitive impairment in patients with parkinson’s disease
    Sergey A. Lytaev, D. S. Susin · 2016 · Pediatrician (St Petersburg)
  10. Enfermedad de Parkinson y parkinsonismos
    F. Carrillo García · 2019 · Medicine - Programa de Formación Médica Continuada Acreditado
  11. Clinical Diagnostic Criteria Have a High Impact on the Frequency of Dementia in Late-Stage Parkinson's Disease
    Catarina Severiano e Sousa, Margherita Fabbri, Catarina Godinho, Rita Moiron Simões, Inês Chendo, Miguel M Coelho, Isabel Pavão Martins, Joaquim José Ferreira · 2021 · Frontiers in Neurology
  12. What are the non-motor symptoms of Parkinson’s disease?
    К. Ray Chaudhuri, Niall Patrick Quinn · 2009 · Oxford University Press eBooks
  13. Parkinson’s Disease Symptoms Associated with Developing On-State Axial Symptoms Early after Subthalamic Deep Brain Stimulation
    Gustavo Fernández‐Pajarín, Ángel Sesar, José Luis Relova, Begoña Ares, Isabel Jiménez, Miguel Gelabert‐González, Eduardo Arán Echabe, Alfonso Castro · 2022 · Diagnostics
  14. Doxycycline Therapeutic Approach in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
    Elaine Del-Bel, Mariza Bortolanza, Glauce Crivelaro Nascimento, Rita Raisman‐Vozari, Maurício dos Santos Pereira, Florencia González‐Lizárraga, Valeria Parrales, Patrick Pierre Michel, Diego Ploper, César L. Ávila et al. · 2022 · Springer eBooks
  15. Effect of clinical autonomic dysfunction on cognitive functions in Parkinson’s disease
    Dursun Aygün, Çetin Kürşad Akpınar, Serpil Kıroğlu Yön, Musa Kazım Onar · 2017 · Dicle Medical Journal / Dicle Tip Dergisi
  16. Altered N400 Congruity Effects in Parkinson’s Disease without Dementia
    Marta Kutas A, Vicente J. Iragui, Yu Niu, Tanya J. D'Avanzo, Jin Yang, David P. Salmon, Lin Zhang, John Olichney · 2014 · Elsevier eBooks
  17. Pallidal Structural Changes Related to Levodopa-induced Dyskinesia in Parkinson's Disease
    Jinyoung Youn, Mansu Kim, Suyeon Park, Ji Sun Kim, Hyunjin Park, Jin Whan Cho · 2022 · Frontiers in Aging Neuroscience
  18. Exploring the Manifestation of Non-motor Symptoms in Parkinson's Disease in a Tertiary Care Center: A Comprehensive Analysis
    Deepak S Gonaboyina, Pragateshnu Das, N. Pradhan, Prerana Dash, Vipin Venugopalan, Santosh Dash · 2025 · Cureus
  19. Cerebral perfusion imaging predicts levodopa-induced dyskinesia in Parkinsonian rat model
    Jarrad Perron, Sophia Krak, Samuel Booth, Dali Zhang, Ji Hyun Ko · 2025 · npj Parkinson s Disease
  20. Context-dependent coupling of posture, gait, and functional mobility under cognitive and sensory demands in Parkinson’s disease
    Elvira Molinero-Martín, Eduardo Villamil-Cabello, Antonio Luque‐Casado, Miguel Fernández‐del‐Olmo · 2025 · Gait & Posture
  21. Neuropathology in genetic Parkinson’s disease: a focused review of pathological and clinical findings
    Pedro Barbosa, Jacy Bezerra Parmera, Thomas T. Warner · 2025 · Journal of Neural Transmission
  22. The challenges of experimental pharmacology in identifying novel treatments for Parkinson's disease
    Margaux Teil, Philippe Huot · 2026 · Current Opinion in Neurobiology
  23. Research Progress on the Mechanism of Ginsenosides in the Treatment of Parkinson’s Disease
    Shanshan Wang, Zhi Chen, Haipeng Tang, Jiyu Gong, Kejin Xu, Kangyu Wang · 2026 · International Journal of Molecular Sciences
  24. A commentary on: “A 12-year population-based study of freezing of gait in Parkinson's disease”
    Jacob J. Crouse, Ahmed A. Moustafa · 2015 · Frontiers in Aging Neuroscience
  25. The Cardiovascular and Cerebrovascular Effects on Cognition in Persons with Parkinson’s Disease: A Systematic Review of the Literature
    Adrianna Carey, Rebecca Julian, Katlyn Kristeller, Peter Leonard, Sara A. Palmer, Laura Krisa · 2015 · Advances in Parkinson s Disease
  26. Very Long-Standing Parkinson's Disease
    Pedro Ruiz, Javier del Val, Antonio S. Herranz · 2013 · European Neurology
  27. The role of specialist nurses in managing Parkinson’s disease
    Lesley Carter · 2006 · Primary Health Care
  28. Levodopa
    David Salat, EDUARDO S. TOLOSA · 2013 · Informa Healthcare eBooks
  29. Review of Physical Signs and Biochemical and Radiological Biomarkers for Detection of Prodromal Parkinson's Disease
    Shrutika Parab, Rajani Mullerpatan, Vipla Puri, Mary Anne J. Joseph, Aarati Kulkarni · 2023 · Critical Reviews in Physical and Rehabilitation Medicine
  30. Activation of mGlu2/3 receptors with the orthosteric agonist LY-404,039 alleviates dyskinesia in experimental parkinsonism
    Woojin Kang, Imane Frouni, Cynthia Kwan, Louis Desbiens, Adjia Hamadjida, Philippe Huot · 2024 · Behavioural Pharmacology
  31. Effect of mGluR2 and mGluR2/3 activators on parkinsonism in the MPTP-lesioned non-human primate
    Imane Frouni, Cynthia Kwan, Dominique Bédard, Adjia Hamadjida, Woojin Kang, Sébastien Belliveau, Stephen G. Nuara, Jim C. Gourdon, Philippe Huot · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  32. Therapy of the Motor Features of Parkinson's Disease
    Susan Helen Fox, Anthony Edward Lang · 2009 · Blue books of neurology
  33. PET-Neuroimaging and Neuropsychological Study for Early Cognitive Impairment in Parkinson’s Disease
    Sergey A. Lytaev · 2022 · Lecture notes in computer science
  34. Current practice in nutrition diagnosis and intervention for the management of P arkinson's disease in A ustralia and C anada
    Jamie M. Sheard, Susan Ash · 2014 · Nutrition & Dietetics
  35. Mild cognitive impairment in Parkinson's disease
    Charles H. Adler · 2009 · Parkinsonism & Related Disorders
  36. Multidisciplinary treatment of Parkinson’s disease: current state and future directions
    Sotirios Andreas Parashos · 2012 · Clinical Practice
  37. Evaluation and delivery of ambulatory rehabilitation for people with Parkinson's disease
    Leah S Goodwin, Ling Lan · 2014 · Reviews in Clinical Gerontology
  38. Psychosis and Parkinson’s Disease
    Christina L. Vaughan, Jennifer G. Goldman · 2012 · Humana Press eBooks
  39. Parkinson’s Disease: Symptoms, Unmet Needs and New Therapeutic Targets
    Monica M. Kurtis, Pablo Martínez‐Martín · 2013 · Royal Society of Chemistry eBooks
  40. NEUROLOGIC DISEASE AND ANESTHESIA
    Deborah J. Culley, Meredith Brooks, Gregory J. Crosby · 2010 · Elsevier eBooks
  41. Gender-related differences in the burden of non-motor symptoms in Parkinson's disease Pablo Martinez-MartinCristian Falup PecurariuPer OdinJacobus J. van Hilten • Angelo AntoniniJose M. Rojo-AbuinVanderci BorgesClaudia Trenkwalder • Dag AarslandDavid J. BrooksKallol Ray Chaudhuri
    Cristian Falup‐Pecurariu, Per Odin, J.J. van Hilten, Angelo Antonini, Vanderci Borges, Sao Paolo, Claudia Trenkwalder, Dag Aarsland, Daniel J. Brooks, К. Ray Chaudhuri · 2012
  42. Parkinson’s Disease and Related Disorders
    Janis M. Miyasaki · 2018 · Springer eBooks
  43. The Impact of Deep Brain Stimulation for Parkinson’s Disease on Couple Satisfaction: An 18-Month Longitudinal Study
    Marc Baertschi, Nicolas Favez, João Flores Alves Dos Santos, Michalina Radomska, François Richard Herrmann, Pierre R. Burkhard, Alessandra Canuto, Kerstin Weber · 2019 · Journal of Clinical Psychology in Medical Settings
  44. Exercise decreases aberrant corticostriatal plasticity in an animal model of l -DOPA-induced dyskinesia
    Ana Elisa Speck, Aderbal S. Aguiar, Samira G. Ferreira, Henrique Bruno Lopes Silva, Ângelo R. Tomé, Paula M. Agostinho, Rodrigo Antunes Cunha, Rui Daniel Prediger · 2021 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  45. Individual Magnetoencephalography Response Profiles to Short-Duration L-Dopa in Parkinson’s Disease
    Edgar Peña, Tareq Mohammad Mohammad, Fedaa Al-Mohammed, Tahani Al-Otaibi, Shahpar Nahrir, Sheraz Khan, Vahe Poghosyan, Matthew D. Johnson, Jawad A. Bajwa · 2021 · Frontiers in Human Neuroscience
  46. Pre-treatment by Rosemary Extract or Cell Transplantation Improves Memory Deficits of Parkinson’s Disease: When Tradition Meets the Future
    Seyyede Narjes Hashemi Rad, Maryam Haji Ghasem Kashani, Kataneh Abrari · 2021 · Brazilian Archives of Biology and Technology
  47. Psychosis
    Eric Molho, Stewart Alan Factor · 2012 · Humana Press eBooks
  48. Review of Active Extracorporeal Medical Devices to Counteract Freezing of Gait in Patients with Parkinson Disease
    Mónica Huerta, Boris Barzallo, Catalina Punín, Andrea García-Cedeño, Roger Clotet · 2022 · Healthcare
  49. Quantification of Non-Motor Symptoms in Parkinsonian Cynomolgus Monkeys
    Yu Bao, Chaoning Gan, Zuyue Chen, Zhongquan Qi, Zhiqiang Meng, Feng Yue · 2023 · Brain Sciences
  50. Pharmacological Properties of Levodopa
    Philippe Huot · 2014 · Springer eBooks
  51. Therapies under investigation for treating Parkinson's disease psychosis
    Niem Tu Huynh, Philippe Huot · 2014 · Clinical Investigation
  52. Parkinson’s Disease Dementia
    Başar Bılgıç, Hasmet Ayhan Hanagasi, Murat Emre · 2014 · Neuropsychiatric symptoms of neurological disease
  53. A multifaceted exercise intervention did not alter cognitive function and cerebral perfusion in individuals with Parkinson's disease
    Brandon S. Pollock, Corey A. Peacock, Emily J. Ryan, Mary Beth Spitznagel, Angela L. Ridgel · 2019 · Science & Sports
  54. Serotonin/dopamine transporter ratio as a predictor of l -dopa–induced dyskinesia
    Philippe Huot, William D. Hutchison · 2015 · Neurology
  55. Electrophysiological and motoric effects of galvanic vestibular stimulation in normal and Parkinson's disease subjects
    Diana Jean-Young Kim · 2013 · cIRcle (University of British Columbia)
  56. Nonmotor Problems in Parkinson Disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett, Peter G. Jenner · 2007 · Elsevier eBooks
  57. Balance dysfunction
    Laurie A. King, Vicki L. Gray, Kody R. Campbell, Prokopios Antonellis · 2024 · Elsevier eBooks
  58. Progression in Parkinson's Disease
    Krithi Irmady, Serge Przedborski · 2025 · Cold Spring Harbor Perspectives in Medicine
  59. Outcomes in Long‐Term Follow‐Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative
    Paulina González-Latapí, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey, David-Erick Lafontant, Yuge Xiao, Caroline M. Tanner, Charles S. Venuto et al. · 2026 · Annals of Neurology
  60. Sleep Disorders in Parkinson’s Disease and Parkinsonian Syndromes
    Hlynur Georgsson, Brian James Murray · 2011 · Elsevier eBooks
  61. D-Ribose-L-Cysteine and L-Dopa Co-Supplementation Attenuates Paraquat-Induced Oxidative Damage and Locomotion Deficit in Drosophila melanogaster
    Adeola Oluwatosin Adedara, Grace Temitope Akingbade · 2024 · Neurochemical Journal
  62. Corpus callosum damage in PSP and unsteady PD patients: A multimodal MRI study
    Maria Eugenia Caligiuri, Andrea Quattrone, Maria Giovanna Bianco, Valerio Riccardo Aquila, Maria Celeste Bonacci, Camilla Calomino, Chiara Camastra, Jolanda Buonocore, Antonio Augimeri, Maurizio Morelli et al. · 2024 · NeuroImage Clinical
  63. Influence of Depression on the Quality of Life in Patients With Parkinson's Disease in Southwest Nigeria
    O. J. Orji, Chimaobi Ezekiel Ijioma, J. E. Odarah, Izuchukwu E Okeji, J. E. Areh, Donatus Onyebuchi Anele, Innocent Chima Zacs, Emmanuel Ayomide Kalesanwo, Ochuko Austin-Jemifor, Uchenna Chika Nnamani · 2024 · Cureus
  64. Psychological assessment of patients with Parkinson's disease
    Abdelaati El Khiat, Driss Ait Ali, Bilal El‐Mansoury, Youssef Ait Hamdan, Adnane Hakem, Lahcen Tamegart, Mohamed El Koutbi, Brahim El Houate, Najib Kissani, Halima Gamrani · 2024 · Elsevier eBooks
  65. Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmoset
    Judy Shaqfah, Dominique Bédard, Stephen G. Nuara, Jim C. Gourdon, Adjia Hamadjida, Fleur Gaudette, Francis Beaudry, Philippe Huot · 2025 · European Journal of Pharmacology
  66. Mirtazapine revisited: new therapeutic perspectives and formulation advances
    Anshula Mehra, Vridhi Sachdeva, Jaanvi Khanna, Gurpreet Singh, Manikay Mahajan, Jyoti Bhardwaj, Maninderdeep Kaur, Neena Bedi · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  67. Dietary tributyrin supplementation in Parkinson’s disease: An open-label target engagement study
    Jeffrey L. B. Bohnen, Stiven Roytman, Travis P. Wigstrom, Robert Vangel, Jaime E Barr, Giulia Carli, Sean M. Parks, Hitasha Mittal, Claire Martino, Prabesh Kanel et al. · 2025 · Neurotherapeutics
  68. Advanced Parkinson’s disease treatment patterns in Italy: results from a multicenter observational study
    Fabrizio Stocchi, Paolo Barone, Roberto Ceravolo, Maria Francesca De Pandis, Leonardo Lopiano, Nicola Modugno, Alessandro Padovani, Manuela Pilleri, Alessandro Tessitore, Mario Zappia · 2026 · Annals of Medicine
  69. Asymmetric Cholinergic Basal Forebrain Atrophy Marks Freezing of Gait in Parkinson's Disease
    Chesney Elizabeth Craig, Prabesh Kanel, Nicola J. Ray, Nicolaas Ida Bohnen · 2026 · European Journal of Neuroscience
  70. Mortality rate, main causes of death and factors associated with higher mortality hazard in late stage Parkinson's disease
    Kristina Rosqvist · 2026 · Journal of Parkinson s Disease
  71. Targeting neuroinflammation and neurodegeneration in Parkinson’s disease: Emerging natural and synthetic therapeutic strategies
    Safia Arbab, Hanif Ullah, Yanting Han, Jiao Zhou, Ka Li · 2026 · Ageing Research Reviews
  72. Rasagilina en monoterapia en pacientes en fases tempranas de la enfermedad de Parkinson y en terapia combinada y coadyuvante a levodopa en fases moderada y avanzada
    Javier Pagonabarraga, María Rodríguez‐Oroz · 2013 · Revista de Neurología
  73. Constipation Treatment in Neurological Disorders
    Luca Gallelli, Domenico Pirritano, Caterina Palleria, De Sarro · 2012 · InTech eBooks
  74. Parkinson’s Disease: Insights from the Laboratory and Clinical Therapeutics
    Jing-ye Zhou, Yong Yu, Xian-Lun Zhu, Chi-Ping Ng, Gang Lü, Wai-Sang Poo · 2012 · InTech eBooks
  75. Complex I Inhibition, Rotenone and Parkinson's Disease
    Ranjita S. Betarbet, J. Timothy Greenamyre · 2008 · Elsevier eBooks
  76. A woman with functional tremor treated with L-DOPA for 14years
    Niem Tu Huynh, Philippe Huot · 2014 · Journal of the Neurological Sciences
  77. Did levodopa vs. dopamine agonist trials teach us when and how to start symptomatic therapy?
    Cheryl Waters · 2009 · Parkinsonism & Related Disorders
  78. Features of dementia as non-motor symptom of Parkinson's disease.
    A. F. Toma, Petru MIHANCEA · 2014
  79. ENFERMEDAD DE PARKINSON, PROYECCIONES FUTURAS, DIAGNÓSTICO PRECOZ, TRATAMIENTO TEMPRANO
    Oscar S. Gershanik · 2008 · Revista Médica Clínica Las Condes
  80. New perspectives in the care of Parkinson disease.
    Irving Asher · 2012 · Europe PMC (PubMed Central)
  81. Parkinson-Syndrom
    Iris Reuter, Guido Knapp · 2013 · Elsevier eBooks
  82. Degenerative Movement Disorders of the Central Nervous System
    Abu A. Qutubuddin, Priya Chandan, William F. Carne · 2020 · Elsevier eBooks
  83. Sleep dysfunction
    Pouya Movahed, Madhuja Tanya Mitra, К. Ray Chaudhuri · 2013 · Informa Healthcare eBooks
  84. Parkinson’s disease
    Kartik Logishetty, К. Ray Chaudhuri · 2009
  85. Idiopathisches Parkinson-Syndrom (IPS)
    Andrés Ceballos-Baumann · 2018 · Springer Reference Medizin
  86. Neuropsychiatric symptoms
    Per Odin, Kerstin Dietrich · 2011
  87. Our Experts Highlight the Most Important Research Articles Across the Spectrum of Topics Relevant to the Field of Neurodegenerative Disease Management
    Susan Helen Fox, Philippe Huot, Bradford Clark Dickerson, Dag Aarsland, Niklas Mattsson, Theresa A. Zesiewicz · 2012 · Neurodegenerative Disease Management
  88. Parkinson’s disease
    Kartik Logishetty, К. Ray Chaudhuri · 2010 · Springer eBooks
  89. Autoradiographic labelling of metabotropic glutamate type 2/3 receptors in the hemi-parkinsonian rat brain
    Esther Kim, Imane Frouni, Judy Shaqfah, Dominique Bédard, Philippe Huot · 2024 · Journal of Chemical Neuroanatomy
  90. Predicting Cognition and Affective Changes in Newly Diagnosed Parkinson’s Disease Through Longitudinal Data-Driven Clustering
    Benjamin Ellul, Angus McNamara, Stephan Lau, Irina Baetu, Mark Jenkinson, Lyndsey E. Collins‐Praino · 2025 · Journal of Geriatric Psychiatry and Neurology
  91. The effect of articulation and word-meaning on gait and balance in people with Parkinson’s disease
    Kevin L. Wood · 2013 · Scholarship@Western (Western University)
  92. Cannabinoids and Levodopa-Induced Dyskinesia
    Andrea Giuffrida, Alex Anthony Martinez · 2014 · Springer eBooks
  93. Epidemiology of Levodopa-Induced Dyskinesia
    Miguel M Coelho, Joaquim José Ferreira · 2014 · Springer eBooks
  94. Clinical Disease Progression in Parkinson’s Disease
    Guido Werner Alves · 2006
  95. Factors associated with Lower Urinary Tract Symptoms for Patients with Parkinson's Disease
    Hyo Jeong Song, Ji‐Hoon Kang, Eun Joo Lee, Jung‐Sik Huh, Young-Joo Kim, Chul Soo Kim, Myung Ja Kim, Seung‐Kyo Chaung, Hye Ja Park, Hyung Chang Kang et al. · 2009 · Journal of Korean Academy of Nursing
  96. Role of Therapeutic Devices in Enhancing Speech Intelligibility and Vocal Intensity in an Individual with Parkinson’s Disease
    Swetha Swaminathan · 2012 · Digital Commons - East Tennessee State University (East Tennessee State University)
  97. A current view on dopamine receptor agonists in the treatment of Parkinson’s disease
    Nataliya Titova · 2015 · S S Korsakov Journal of Neurology and Psychiatry
  98. Adaptive Brain Stimulation for Parkinson's Disease
    Martijn Beudel · 2016 · Elsevier eBooks
  99. Psychiatrische Begleiterkrankungen im Rahmen einer Parkinson-Demenz
    Lina Riedl, Urban M. Fietzek · 2018 · neuroreha
  100. In Vivo Positron Emission Tomography of Extrastriatal Non-Dopaminergic Pathology in Parkinson Disease
    Martijn L.T.M. Müller, Nicolaas Ida Bohnen · 2018 · Contemporary clinical neuroscience